Vickers Troy, Dyck Brian, Tamiya Junko, Zhang Mingzhu, Jovic Florence, Grey Jonathan, Fleck Beth A, Aparicio Anna, Johns Michael, Jin Liping, Tang Hui, Foster Alan C, Chen Chen
Department of Medicinal Chemistry, Neurocrine Bioscience, Inc., 12790 El Camino Real, San Diego, CA 92130, USA.
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3230-5. doi: 10.1016/j.bmcl.2008.04.045. Epub 2008 Apr 25.
A series of milnacipran analogs containing a heteroaromatic group were synthesized and studied as monoamine transporter inhibitors. Many compounds exhibited higher potency than milnacipran at NET and NET/SERT with no significant change in lipophilicity. For example, compound R-26f was about 10-fold more potent than milnacipran with IC(50) values of 8.7 and 26nM at NET and SERT, respectively.
合成了一系列含有杂芳基的米那普明类似物,并将其作为单胺转运体抑制剂进行研究。许多化合物在去甲肾上腺素转运体(NET)和去甲肾上腺素/5-羟色胺转运体(NET/SERT)上表现出比米那普明更高的效力,且亲脂性无显著变化。例如,化合物R-26f的效力比米那普明高约10倍,在NET和SERT上的半数抑制浓度(IC50)值分别为8.7和26 nM。